Tri Locum Partners »

Merus N V shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 286k 45.03
2023-06-30 $2.7M 102k 26.33

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Silk Road Medical Inc Common (SILK)
Natera (NTRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Legend Biotech Corp Sponsored Ads (LEGN)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Madrigal Pharmaceuticals (MDGL)
Baxter International (BAX)
Merus N V (MRUS)
Tandem Diabetes Care Com New (TNDM)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Regeneron Pharmaceuticals (REGN)

View all positions for Tri Locum Partners

Top funds holding Merus N V

Commodore Capital
Federated Investors
Deerfield Management Company
Samlyn Capital
Wellington Management Company
Boxer Capital
Franklin Resources
VR Adviser
FMR
Lynx1 Capital Management
BlackRock
T. Rowe Price Associates
BVF
Medicxi Ventures Management
Rock Springs Capital Management

View all funds holding Merus N V